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Phosphorylation of the heat shock–related protein,
HSP20, mediates cyclic nucleotide-dependent
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Cyclic nucleotide-dependent relaxation of vascular smooth muscle is associated with increases in the phosphorylation of
the small heat shock–related protein, HSP20. To determine whether phosphorylated HSP20 directly mediates relaxation,
we used gene transfection and protein transduction of HSP20 analogues. Rat mesangial cells were transfected with
constructs containing wild-type HSP20-enhanced green fluorescent protein (EGFP), phosphorylation site mutated
HSP20 (S16A-HSP20-EGFP), or EGFP alone. Contractile properties were determined on a silicone polymer substrata.
In the presence of serum, EGFP-vector transfected control cells and S16A-HSP20 transfected cells formed wrinkles on
the polymer (contracted). Activation of cyclic nucleotide signaling pathways in the EGFP-vector transfected control cells
led to a time-dependent decrease in the wrinkles (relaxation). The S16A-HSP20 transfected cells were refractory to cyclic
nucleotide-dependent relaxation. Cells overexpressing the wild-type HSP20 did not form wrinkles on the polymer in
response to serum (refractory to contraction). Treatment of precontracted strips of intact bovine carotid artery smooth
muscle with synthetic peptides containing HIV-trans-activating transcriptional activator and a phosphopeptide motif of
HSP20 led to dose-dependent relaxation. These data provide evidence that phosphorylated HSP20 has a direct role in
smooth muscle relaxation and that small phosphopeptide motifs of HSP20 can mimic the effects of the entire molecule.
(J Vasc Surg 2003;37:874-81.)
Blood vessels are comprised of two major cell types,
endothelial cells and vascular smooth muscle cells. The
discovery that endothelial cells are capable of producing a
substance (nitric oxide) that relaxes the underlying smooth
muscle cells has been the cornerstone of the field of vascular
biology. Nitric oxide is a cell-permeable gas that interacts
with a heme containing moiety in the guanylyl cyclase
enzyme of the smooth muscle cells, leading to increases in
intracellular guanosine 3:5-cyclic monophosphate
(cGMP). -adrenergic agonists and prostacyclin are other
agents that relax vascular smooth muscle by receptor me-
diated activation of adenylyl cyclase, leading to increases in
adenosine 3:5-cyclic monophosphate (cAMP). Cyclic
GMP and cAMP activate cGMP-dependent protein kinase
(PKG) and cAMP-dependent protein kinase (PKA), re-
spectively. However, the specific proteins phosphorylated
by these kinases that are necessary for relaxation to occur
have not been well established.
Agonist-induced increases in intracellular Ca2 con-
centrations, activation of Ca2/calmodulin-dependent
myosin light chain kinase, and increases in the phosphory-
lation of the regulatory myosin light chains (MLC20) have
been implicated in the initiation of smooth muscle contrac-
tion.1 Thus, most previous investigations have suggested
that cyclic nucleotide-dependent relaxation occurs through
inhibition or reversal of the Ca2/myosin light chain ki-
nase/MLC20 pathway. However, a fundamental paradox
in smooth muscle physiology is that increases in intracellu-
lar Ca2 concentrations and MLC20 phosphorylation are
transient in the continued presence of a contractile agonist
even though force is maintained.2 In addition, activation of
cyclic nucleotide-dependent signaling pathways inhibits
the development of force in response to contractile agonists
but does not inhibit increases in either the phosphorylation
of MLC20 or in energy consumption (which in smooth
muscle is largely from cross-bridge cycling).3,4 This disso-
ciation between the state of MLC20 phosphorylation and
force production suggests that mechanisms other than
thick filament (myosin and MLC20) regulation are opera-
tive in contraction and relaxation of smooth muscle. In
addition, these data suggest that cyclic nucleotide-depen-
dent relaxation does not simply involve a reversal or inhi-
bition of the signaling pathways that initiate contraction.
A recently identified substrate protein of both PKG and
PKA is the small heat shock–related protein, HSP20.5
HSP20 is highly and constitutively expressed in muscle
tissues. HSP20 shares considerable sequence homology to
the other small heat shock proteins, HSP27, myotonic
dystrophy kinase binding protein, and the crystallins. The
family of small heat shock proteins has been implicated in
modulating cytoskeletal dynamics. Increases in the phos-
phorylation of HSP20 are associated with cyclic nucleotide-
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dependent relaxation of vascular smooth muscle and inhi-
bition of agonist-induced contraction of smooth muscle.4,5
HSP20 is not phosphorylated in umbilical artery smooth
muscle, which is uniquely refractory to cyclic nucleotide-
dependent relaxation.6 These data suggest that there is a
correlation between increases in the phosphorylation of
HSP20 and cyclic nucleotide-dependent relaxation.
METHODS
Materials. Serum albumin (bovine calf), Dulbecco’s
modified minimal essential medium, glutamine, penicillin,
and streptomycin were purchased from Gibco (Grand Is-
land, NY). Urea, sodium dodecylsulfate (SDS), glycine,
and tris-(hydroxymethyl) aminomethane (Tris) were from
Research Organics (Cleveland, Ohio). Forskolin, dibutyryl
cAMP, and dibutyryl cGMP were from Calbiochem (La
Jolla, Calif). Piperazine diacrylamide and other electro-
phoresis reagents were from Biorad (Hercules, Calif). 3-
[3-cholamidopropyl dimethylammonio]-1-propanesulfon-
ate, ethylene glycol bis (-aminoethyl ether)-N, N, N,
N-tetra acetic acid, ethylenediamine tetraacetic acid,
polyoxyethylene-sorbitan monolaurate (Tween-20), so-
dium nitroprusside, and all other reagent grade chemicals
were from Sigma (St Louis, Mo). Polyclonal antibodies
against HSP20 were a gift from Kanefusa Kato (Aichi,
Japan),7 and PKG antibodies were purchased from Stress-
Gen Biotechnology, Inc (Victoria, British Columbia, Can-
ada). Goat antirabbit secondary antibodies were from Jack-
son Immunochemical (West Grove, Pa). Protein
concentrations were determined with the Coomassie Plus
Protein Assay Reagent (Pierce, Rockford, Ill). The peptides
fluoroscein isothiocyanate (FITC)–NH2-AGGGGY
GRKKRRQRRRWLRRAS*APLPGLK-COOH, (FITC




TAT; *denotes a phospho-serine) were synthesized by Cell
Essentials (Boston, Mass).
Mesangial cell culture. Rats were anesthetized with
ether and exanguinated, and the kidneys were removed.
The renal cortex was minced, and the glomeruli were
isolated with rinsing the minced tissue through a stainless
steel sieve. The glomeruli were plated in Dulbecco’s mod-
ified minimal essential medium containing 20% inactivated
fetal calf serum, 4 mmol/L L-glutamine, 5 g/mL bovine
insulin, 50 U/mL penicillin/mL, and 50 g/mL strepto-
mycin. Cells were plated in 35-mm petri dishes at a density
of 10,000 cells/dish, and passages 4 to 8 were used for
experiments.
Two-dimensional gel electrophoresis. Proteins
were separated with two-dimensional gel electrophoresis as
previously described.5 In brief, 150 g of protein was
loaded onto 12 15–cm slab isofocusing gels consisting of
4% acrylamide, 0.1% piperazine diacrylamide, 9 mol/L
urea, 5% ampholines (5 parts 6 to 8, 3 parts 5 to 7, and 2
parts 3 to 10), and 2% 3-[3-cholamidopropyl dimethylam-
monio]-1-propanesulfonate. Temed (0.04%) (Bio-Rad,
Hercules, Calif) and ammonium persulfate (0.1%) were
used to initiate polymerization. The cathode buffer con-
sisted of 20 mmol/L sodium hydroxide, and the anode
buffer of 10 mmol/L phosphoric acid. The proteins were
focused for 10,000 volt hours. The gels were fixed in 10%
trichloroacetic acid and stained with Neuhoff’s coomassie
stain, and the lanes of stained proteins were cut from the
isofocusing slab gels and equilibrated in 10 mmol/L Tris
(pH, 6.8), 3% SDS, 19% ethanol, 4% -mercaptoethanol,
and 0.004% bromophenol blue for 10 minutes. The pro-
teins then were separated on 15% SDS-polyacrylamide gels.
The gels were transferred and probed as described previ-
ously.
Immunoblotting. Cells were harvested from 60-mm
culture dishes in 10 mmol/L ethylene glycol bis (-amino-
ethyl ether)-N, N, N, N-tetra acetic acid, 2 mmol/L
ethylenediamine tetraacetic acid, 10 mmol/L -mercapto-
ethanol, 1% glycerol, and 4% SDS in 60 mmol/L Tris, pH
7.0, followed by centrifugation (14,000 xg) to remove
insoluble material. The extracts (30 g protein) were re-
solved with SDS polyacrylamide gel electrophoresis and
transferred to Immobilon (Millipore, Bedford, Mass) for
210 volt hours. The blots were dried and blocked with
tris-buffered saline solution (TBS) consisting of 10
mmol/L Tris-Cl, pH 7.4, 150 mmol/L NaCl, 0.05%
Tween, and 5% nonfat dried milk for 1 hour. The blots were
incubated with anti-PKG (1:5000) or HSP20 (1:5000). All
antibodies were incubated with the blots in TBS/milk
overnight at 4° C. After washing (three times for 5 minutes
each) in TBS–Tween-20 (0.5%), immunoreactive proteins
were determined with SuperSignal Chemiluminescence kit
(Pierce).
Site-directed mutagenesis. The complementary
DNA (cDNA) for HSP208 was cloned into plasmid en-
hanced green fluorescent protein-C terminal expression
vector (Clontech, Palo Alto, Calif). HSP20-S16A mutant
was produced with a single nucleotide mutation in the
HSP20 cDNA sequence with a two complimentary oligo-
nucleotide strategy with pyrococus furiosis polymerase
(Stratagene, La Jolla, Calif). All sequences were confirmed
for orientation, the presence of the appropriate mutations,
and the absence of other mutations with a 377 ABI Prism
DNA sequencer (Perkin-Elmer, Foster City, Calif).
Mesangial cell transfection. Mesangial cells were
plated in 60-mm dishes, 200,000 per dish, which resulted
in 40% to 80% confluence in 24 hours. Transfections were
performed with the Quiagen Transfection Kit (# 301425)
(Valencia, Calif) according to the manufacturer’s recom-
mendations. In brief, the different HSP20 DNA constructs
(1.5g) were diluted to 150L with buffer. Enhanced add
(8 L) was added, and the sample was vortexed and then
incubated at room temperature for 5 minutes. Effectine
Transfection Reagent (Quiagen) (25 L) was added, and
the samples were vortexed and then incubated for 10
minutes at room temperature. Media (1 mL; 37° C) were
added to the samples, and the samples were triturated and
added to the mesangial cell cultures. The cells were incu-
bated with the transfection complexes for 24 hours. The
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media were aspirated, and fresh media were added to the
dishes. The cells were trypsinized and plated on sputter
coated silicone in 35-mm dishes. Transfection efficiencies
varied between 5% and 15%.
Measurement of contractile responses of mesangial
cells on silicone polymer substrata. The silicone poly-
mer9 substratum was prepared with spreading a thin film of
silicone, Dimethylpolysiloxane, (Sigma DMPS-60m) onto
35-mm petri dishes. The silicone was allowed to spread
under gravity until the surface was smooth. A vacuum was
pulled (150 to 200 millitorr) on a Technics Hummer II
Electron Microscope Sputter Coater (Anatech, Alexandria,
Va) on each dish before sputter coating for 15 seconds at 15
mA and 11 volts to form a thin coat of gold/palladium on
the surface of the silicone. The dishes were sterilized with
ultraviolet lighting before plating 10,000 mesangial cells
per dish.
The culture dishes with mesangial cells were placed on
the stage of a Zeiss Inverted Fluorescence Microscope with
DeltaVision image acquisition and deconvolution software
(Applied Precision, Issaquah, Wash). The DeltaVision soft-
ware was configured to eight different cells (x and y axis) on
each plate with seven z-axis images taken at 2-nm intervals.
Fluorescence and phase images were obtained such that the
cells and silicone membrane were imaged in close succes-
sion. During the scanning process, the z axis of each cell was
monitored to assure that the imaging stacks were main-
tained at the appropriate level as the cells relaxed on the
silicone membrane. Baseline images were acquired for 1
hour. The cells then were treated with the cyclic nucleotide
analogues or activators, and images were acquired every 15
minutes.
Immunofluorescent staining. Mesangial cells were
grown on glass slides and incubated with 10 mol/L
dibutyryl cAMP (Sigma) for 2 hours or with PBS. The cells
were then rinsed three times with phosphate-buffered sa-
line solution (PBS) at 4° C. The slides were fixed in 4%
paraformaldehyde (in PBS; pH, 7.4) for 20 minutes. The
cells then were rinsed three times in PBS at 4° C and then
treated with 0.1% Triton X-100 (Sigma, St Louis, Mo) for
5 minutes. The cells were rinsed three times with PBS at
4° C. The cells were incubated with rhodamine phalloidin
(Molecular Probes, Eugene, Ore) diluted 1:40 in 0.1%
bovine serum albumin/PBS for 20 minutes at room tem-
perature. The cells were washed with PBS, and the slides
mounted. Images were captured on a Zeiss Axiophot mi-
croscope (Carl Zeiss, Inc, Munchen-Hallbergmoos, Ger-
many) interfaced with a SPOT camera (Diagnostic Instru-
ments, Inc, Sterling Heights, Mich) and a Gateway
computer (Gateway, North Sioux City, SD).
Treatment of intact strips of vascular smooth mus-
cle with phosphopeptide analogues of HSP20. Bovine
carotid arteries were dissected from fetal calves at a local
abattoir (Shapiro’s, Augusta, Ga) and placed directly in
N-(2-hydroxyethyl)piperazine-N-(2-ethane-sulfonic acid)
buffer (140 mmol/L NaCl, 4.7 mmol/L KCl, 1.0
mmol/L MgSO4, 1.0 mmol/L NaH2PO4, 1.5 mmol/L
CaCl2, 10 mmol/L glucose, and 10 mmol/L HEPES, pH
7.4) and stored at 4° C for 24 to 72 hours. The carotid
vessels were dissected free from the adventitia and were
opened longitudinally. The endothelium was removed with
rubbing the intima with a cotton-tipped applicator. Trans-
verse strips, 1.0 mm in width, were cut, and each end was
tied to a loop of 3-0 silk. The tissue was suspended in a
muscle bath containing a bicarbonate buffer (120 mmol/L
NaCl, 4.7 mmol/L KCl, 1.0 mmol/L MgSO4, 1.0
mmol/L NaH2PO4, 10 mmol/L glucose, 1.5 mmol/L
CaCl2, and 25 mmol/L Na2HCO3, pH 7.4), equilibrated
with 95% O2/5% CO2, at 37° C. The strips were fixed at
one end to a stainless steel wire and attached to a Kent
Scientific (Litchfield, Conn) force transducer (TRN001)
interfaced with a Data Translation A-D board, DT2801
(Data Translation, Inc, Marlboro, Mass). Data were ac-
quired with Dasylab software (Dasytec, Amherst, Mass).
The strips then were progressively stretched, and the iso-
metric force generated in response to 110 mmol/L KCl
(with equimolar replacement of NaCl in bicarbonate
buffer) determined until the consistent maximal force was
produced. The muscles were precontracted with serotonin
(1 mol/L) for 10 minutes, and cumulative doses of
FITC-TAT-phospho HSP20 peptide analogues were
added every 5 minutes.
RESULTS
Phosphorylation of HSP20 with activation of cyclic
nucleotide-dependent signaling pathways in mesangial
cells. The contractile phenotype and expression of PKG
and HSP20 are lost as smooth muscle cells are passaged in
culture. Mesangial cells have been shown to maintain a
contractile phenotype in culture.9 These cells express both
PKG and HSP20, whereas multiply cultured rat aortic
vascular smooth muscle cells do not (Fig 1). Thus, to
determine whether HSP20 could be phosphorylated with
activation of cyclic nucleotide-dependent signaling path-
ways, mesangial cells were treated with dibutyryl cAMP (10
mol/L, for 15 minutes) and phosphorylation of HSP20
was examined with polyclonal antibodies that recognize all
isoforms (phosphorylated and nonphosphorylated) of
HSP20. In untreated mesangial cells, HSP20 was present
in a basic, nonphosphorylated isoform (Fig 2). Treatment
with dibutyryl cAMP led to a shift of some of the HSP20 to
a more acidic (phosphorylated) isoform (Fig 2).
Physiologic responses of mesangial cells transfected
with HSP20. To determine the effects of overexpressing
HSP20 or of a nonphosphorylatable mutant HSP20, mes-
angial cells were transfected with wild HSP20 cDNA or
HSP20 in which serine 16 was mutated to alanine. The
constructs contained the expression sequence for enhanced
green fluorescent protein (EGFP) to identify transfected
cells. Physiologic responses (wrinkle formation) were de-
termined with a silicone polymer as described previously.9
Mesangial cells transfected with EGFP vector alone ad-
hered to the matrix, and in the presence of serum, discreet
wrinkles formed under the cells (Fig 3). This wrinkle for-
mation has been attributed to contraction of the cells.9
Treatment with dibutyryl cAMP (10 mol/L) led to a
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progressive disappearance of the wrinkles (relaxation) over
time (Fig 3). Mesangial cells transfected with wild type
HSP20 adhered to the matrix but did not form wrinkles
when cultured in the presence of serum (Fig 3). The cells
transfected with the S16A-HSP20 formed wrinkles that did
not disappear after treatment with cyclic nucleotide ana-
logues (Fig 3). Similar findings were observed when cyclic
nucleotide-dependent signaling pathways were activated
with sodium nitroprusside (10 mol/L), dibutyryl cGMP
(10 mol/L), or forskolin (10 mol/L; data not shown).
There were no changes in the wrinkles in the substrata in
untreated cells imaged for 90 minutes (data not shown).
Immunofluorescent staining of transfected mesan-
gial cells. The small heat shock proteins have been impli-
cated in modulating cytoskeletal dynamics. It is likely that
contraction and relaxation of smooth muscle requires a
dynamic cytoskeleton. Thus, to determine whether HSP20
modulates thin filament dynamics, transfected mesangial
cells were fixed and the actin filaments were stained with
phalloidin. Mesangial cells transfected with the EGFP con-
struct showed abundant stress fibers (Fig 4). Activation of
cyclic nucleotide-dependent signaling pathways with treat-
ment with dibutyryl cAMP (10 _mol/L, 120 minutes) led
to a decrease in the stress fibers, with fibers present only at
the cell periphery (Fig 4). Cells transfected with the wild-
type HSP20 constructs had few stress fibers, which were
localized to the periphery of the cell, and the distribution of
the stress fibers did not change with dibutyryl cAMP treat-
ment (Fig 4). S16A-HSP20 mutants had abundant stress
fibers throughout the cells, and the localization of the stress
fibers did not change with dibutyryl cAMP treatment.
Phosphopeptide analogues of HSP20 relax vascular
smooth muscle. Recent studies have shown that peptides
and proteins fused to the protein transduction domain
from the human immunodeficiency virus TAT protein are
Fig 1. HSP20 expression in vascular smooth muscle and mesan-
gial cells. Homogenates of mesangial cells (MCs; passage 8), rat
aortic smooth muscle cells (SMCs; passage 12), and PKG trans-
fected rat aortic smooth muscle cells (PKG/SMC) were immuno-
blotted for PKG or HSP20. Relative mobility of molecular weight
markers is depicted on left of blots. Immunoreactive PKG and
HSP20 are denoted with arrows.
Fig 2. HSP20 phosphorylation in cultured mesangial cells. Mes-
angial cells were untreated (A) or treated with dibutyryl cAMP (B;
10 mol/L, for 15 minutes) and homogenized, and proteins were
separated with two-dimensional electrophoresis. Gels then were
transferred to Immobilon and probed with polyclonal antibodies
that recognize all isoforms (phosphorylated and nonphosphory-
lated) of HSP20. Increases in phosphorylation of HSP20 lead to
shift in electrophoretic mobility of some protein to more acidic
isoform (arrow). This blot is representative of three separate
experiments.
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rapidly incorporated into cells in a concentration-depen-
dent fashion that is independent of receptors or transport-
ers.10 Phosphopeptide analogues of HSP20 were synthe-
sized containing the TAT sequence and FITC.
Transduction of precontracted strips of intact bovine co-
rotid artery smooth muscle with the FITC-TAT-HSP20
phosphopeptide led to a dose-dependent decrease in sero-
tonin precontracted muscles (Fig 5). Peptides containing
the scrambled sequence or FITC-TAT alone had no signif-
icant effect on contractile force (Fig 5). There was a diffuse
fluorescence staining pattern of the muscle strips after
transduction with the FITC-TAT-HSP20 phosphopeptide
(Fig 5).
DISCUSSION
This study used two distinct approaches to further
define the physiologic function of HSP20, genetically en-
gineering cultured mesangial cells and protein transduction
of intact vascular smooth muscles. Because vascular smooth
muscle cells lose their contractile properties after multiple
passages in culture,11 a well-defined model of renal glomer-
ular mesangial cells was used for gene transfection. Cul-
tured renal glomerular mesangial cells are muscle-like cells
in which physiologic contraction and relaxation responses
can be determined when the cells are cultured on a silicone
substrata.9 Multiply passaged mesangial cells maintain their
contractile phenotype and continue to express PKG12 and
HSP20 (Fig 1). HSP20 can be phosphorylated in renal
mesangial cells in response to activation of cyclic nucleoti-
de-dependent signaling pathways (Fig 2). Thus, these cells
provide a useful model for genetic engineering to deter-
mine the function of HSP20.
Dual phase and fluorescence microscopy was used to
identify cells transfected with constructs containing HSP20
and EGFP. In cells that were transfected with EGFP alone,
activation of cyclic nucleotide-dependent signaling path-
ways leads to a time-dependent disappearance of the wrin-
kles (Fig 3). However, cells overexpressing wild-type
HSP20 did not form wrinkles in the underlying substrata.
This suggests that overexpression of HSP20 inhibits se-
rum-induced contraction of the cells. Activation of cyclic
nucleotide-dependent signaling pathways in strips of intact
vascular smooth muscle (which leads to phosphorylation of
HSP20) also inhibits agonist-induced contraction.3 Fi-
nally, cells that expressed a mutated form of HSP20 in
which the phosphorylation site (serine 16) had been
changed to an alanine formed wrinkles that did not disap-
pear with activation of cyclic nucleotide-dependent signal-
ing pathways. These data suggest that expression of wild-
type HSP20 inhibits contraction of the cells and expression
of the S16A-HSP20 mutated protein inhibits relaxation.
Genetically engineering cells is a common tool to char-
acterize the function of a specific protein. However, there is
a delay in the expression of the target protein, high trans-
Fig 3. Physiologic responses of HSP20 transfected mesangial cells. Mesangial cells were transfected with vectors
containing EGFP alone, EGFP fused to 5¢ end of wild-type cDNA for HSP20 (WT-EGFP), or EGFP fused to HSP20
construct in which PKA phosphorylation site (serine 16) was mutated to alanine (MUT-EGFP). Cells were plated on
silicone polymer in presence of serum, and after 48 hours, cells were treated with dibutyryl cAMP (10 mol/L) for 0
minutes, 30 minutes, 60 minutes, or 90 minutes. Phase contrast (blue) and fluorescent (green) images were captured
with DeltaVision microscope (A). Quantitative results are depicted in B, where cells transfected with EGFP alone are
represented with closed circles, mutated HSP20 with open circles, and wild-type HSP20 with closed triangles. This figure
is representative of six separate transfections in which at least 12 cells were imaged with each construct and aggregate
data are depicted (*P  .05 compared with initial number of wrinkles).
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fection efficiencies are difficult to obtain, and this approach
is best suited for cultured cells. Although the transfection of
mesangial cells with HSP20 constructs led to alterations in
physiologic properties as determined on a silicone polymer,
these responses are not necessarily analogous to vascular
smooth muscle contraction and relaxation. Thus, we engi-
neered peptides that contained a protein transduction do-
main and the biologically active peptide motifs of HSP20.
Chemical coupling of the protein transduction domain
of HIV TAT protein to several proteins and peptides allows
Fig 4. Actin stress fiber dynamics. Mesangial cells were transfected with EGFP alone (EGFP), S16A-HSP20
(MUT-EGFP), or wild-type HSP20 (WT-EGFP). Cells were plated on glass slides and left untreated (CONT) or
treated with dibutyryl cAMP (db-cAMP; 10 mol/L, for 30 minutes). Cells were fixed and stained with rhodamine
phalloidin. Green fluorescence indicates presence of EGFP, and red fluorescence the actin stress fibers (magnification,
63).
Fig 5. Treatment of intact strips of vascular smooth muscle with phosphopeptide analogues of HSP20. Transverse
strips of bovine carotid artery smooth muscle, denuded of endothelium, were suspended in muscle bath as described in
Methods. Muscles then were precontracted with serotonin (1 mol/L) for 10 minutes, and cumulative doses of
FITC-TAT-phospho HSP20 (closed circles), FITC-TAT scrambled phospho HSP20 (open circles), or FITC-TAT
(closed triangles) were added every 5 minutes (A). Force is depicted as percentage of maximal serotonin contraction
(force generated by serotonin before addition of peptide is taken as 100%; n 5; *P  .05 compared with no peptide
added or two controls). Representative strips treated with FITC-TAT-phospho HSP20 (1.0 mmol/L) were fixed in 4%
paraformaldehyde and examined with fluorescence microscopy (B; magnification,40). Media (M) and adventitia (A)
are identified to right of panel.
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their functional internalization into cell lines or tissues.10
We have previously determined that reversibly permeabiliz-
ing vascular smooth muscle and the introduction of a small
(13 amino acid) phosphopeptide analogue of HSP20 in-
hibits agonist-induced contraction.13 Thus, synthetic pep-
tides were constructed containing the 11 amino acid TAT
domain and the 13 amino acid HSP20 domain. The addi-
tion of this synthetic peptide analogue of HSP20 to agonist
precontracted strips of vascular smooth muscle led to a
dose-dependent relaxation response (Fig 5). Peptides con-
taining the protein transduction domain alone or the pro-
tein transduction domain coupled to a random orientation
of the same amino acids did not relax the muscles. These
data provide direct evidence that the protein transduction
can be used to specifically alter physiologic responses in
vascular smooth muscle. These data also confirm that the
small peptide domain sequences surrounding the phos-
phorylation site of HSP20 can mimic the effects of the
entire HSP20 molecule.
Cellular processes such as cell adhesion, cytokinesis, cell
motility, migration, and contraction all require dynamic
reorganization of the actin cytoskeleton. The small heat
shock proteins HSP27 and HSP20 have attracted consid-
erable interest as modulators of actin filament dynamics.
HSP27 is closely related to HSP20. The two proteins often
coexist in macromolecular aggregates.14,15 HSP20 and
HSP27 are both actin-associated proteins.16,17 Although
HSP27 has been examined more closely than HSP20, these
two proteins appear to have opposing functions. Increases
in the phosphorylation of HSP27 are associated with
smooth muscle contraction,18 whereas increases in the
phosphorylation of HSP20 are associated with relaxation.5
Phosphorylated HSP27 inhibits the phosphorylation of
HSP20 in vitro.19 Transfection of cells with dominant
active phosphorylated mutants of HSP27 leads to abun-
dant stress fiber formation,20 whereas overexpression of
HSP20 or protein transduction with phospho-analogues of
HSP20 leads to a loss of central stress fibers (Fig 4). Finally,
increases in the phosphorylation of HSP27 are associated
with smooth muscle migration,21 whereas transduction of
phosphorylated peptide analogues of HSP20 inhibits mi-
gration (Brophy and Kent, unpublished data). Taken to-
gether, these data support further investigation into the
role HSP20 plays in modulating actin filament dynamics
and in intimal hyperplasia.
In summary, HSP20 may mediate relaxation via a thin
filament (actin) regulatory mechanism. The two small heat
shock proteins modulate thin filament cytoskeletal dynam-
ics through alterations in phosphorylation or macromolec-
ular associations. These data also suggest that heat shock
proteins have distinct physiologic functions beyond their
well-established roles in stress tolerance and as molecular
chaperones. Taken together, these data suggest that the
phosphorylation of HSP20 represents a point in which the
cyclic nucleotide signaling pathways converge to prevent
contraction or cause relaxation (Fig 6).
We thank Dr Howard Rasmussen for his guidance and
insight.
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